HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 279, Issue 5, 3869-3876, January 30, 2004

This Article Full Text Full Text (PDF) All Versions of this Article: 279/5/3869    most recent M305880200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shibazaki, M. Articles by Kikuchi, H. Search for Related Content PubMed PubMed Citation Articles by Shibazaki, M. Articles by Kikuchi, H. Social Bookmarking                      What's this?

Suppression by p38 MAP Kinase Inhibitors (Pyridinyl Imidazole Compounds) of Ah Receptor Target Gene Activation by 2,3,7,8-Tetrachlorodibenzo-p-dioxin and the Possible Mechanism^*

Masahiko Shibazaki, Takashi Takeuchi, Sohel Ahmed, and Hideaki Kikuchi

From the Department of Molecular Genetics, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan

Cytochrome P-450 1A1 (CYP1A1) is known to be induced by aromatic hydrocarbons, such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), through activation of the aryl hydrocarbon receptor (AhR). We found that p38 MAP kinase inhibitors (SB203580 and SB202190; 40 µM each; pyridinyl imidazole compounds) suppressed CYP1A1-mRNA induction by TCDD (2 nM) in mouse hepatoma Hepa-1 cells and in human hepatoma HepG2 cells, and also suppressed CYP1B1-mRNA induction by TCDD (2 nM) in human breast adenocarcinoma MCF7 cells. An analogue compound, SB202474, which does not inhibit p38 MAP kinase, also suppressed CYP1A1-mRNA induction by TCDD. Moreover, overexpression of a dominant-negative gene for p38 MAP kinase in Hepa-1 cells did not suppress Cyp1a1 reporter gene induction by TCDD. Therefore, the suppression of Cyp1a1 transcription by pyridinyl imidazole compounds is not because of their inhibition of p38 MAP kinase activity. Because SB203580 did not inhibit in vitro AhR transformation by TCDD, this compound was not acting as a simple AhR antagonist. SB203580 decreased TCDD-induced histone acetylation levels in the region of the Cyp1a1 gene promoter, especially around the TATA box sequence. This result suggests the possibility that pyridinyl imidazole compounds suppress the recruitment of some co-activator that has the histone acetyltransferase activity necessary for CYP1A1-mRNA transcription.

Received for publication, June 4, 2003 , and in revised form, October 31, 2003.

^* This work was supported in part by Grants-in-aid for Scientific Research (B) 11558068 and 12480153 and Exploratory Research 12878090 and 13878099 from the Ministry of Education, Culture, Sports, Science and Technology (Monbu Kagakusho). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Supported by a grant from the Japan Society for the Promotion of Science (JSPS). Current address: Peptide Biosignal Engineering Research Unit, Mitsubishi Kagaku Institute of Life Sciences, 11 Minamiooya, Machida, Tokyo 194-8511, Japan.

To whom correspondence should be addressed: Dept. of Molecular Genetics, Institute of Development, Aging and Cancer, Tohoku University, 4-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi Japan. Tel.: 81-22-717-8469; Fax: 81-22-717-8470; E-mail: hkikuchi{at}idac.tohoku.ac.jp.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				Z. Han, Y. Miwa, H. Obikane, M. Mitsumata, F. Takahashi-Yanaga, S. Morimoto, and T. Sasaguri Aryl hydrocarbon receptor mediates laminar fluid shear stress-induced CYP1A1 activation and cell cycle arrest in vascular endothelial cells Cardiovasc Res, March 1, 2008; 77(4): 809 - 818. [Abstract] [Full Text] [PDF]

				T. Suzuki and K. Nohara Regulatory Factors Involved in Species-specific Modulation of Arylhydrocarbon Receptor (AhR)-dependent Gene Expression in Humans and Mice J. Biochem., October 1, 2007; 142(4): 443 - 452. [Abstract] [Full Text] [PDF]

				K P Lai, M H Wong, and C K C Wong Inhibition of CYP450scc expression in dioxin-exposed rat Leydig cells J. Endocrinol., June 1, 2005; 185(3): 519 - 527. [Abstract] [Full Text] [PDF]

				S. Chen, T. Operana, J. Bonzo, N. Nguyen, and R. H. Tukey ERK Kinase Inhibition Stabilizes the Aryl Hydrocarbon Receptor: IMPLICATIONS FOR TRANSCRIPTIONAL ACTIVATION AND PROTEIN DEGRADATION J. Biol. Chem., February 11, 2005; 280(6): 4350 - 4359. [Abstract] [Full Text] [PDF]

				Z.-H. Chen, Y.-J. Hurh, H.-K. Na, J.-H. Kim, Y.-J. Chun, D.-H. Kim, K.-S. Kang, M.-H. Cho, and Y.-J. Surh Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells Carcinogenesis, October 1, 2004; 25(10): 2005 - 2013. [Abstract] [Full Text] [PDF]